Member Info for Uncanny

Sorry, forgot to mention possible lab revenues too!

PP, l certainly hope so but the last two LinkedIn posts suggest ME has started looking for partnering / financing options now which is a little worry as I thought that this was already in hand when I believe perhaps May is the last amount of the last fundraise available, albeit obviously something needs to be done before May so perhaps could be April but I certainly hope I’m wrong with an 8 figure shareholding But the months after Christmas will fly by!? 🤔

As many were very wrong, I have not sold out but have just de-risked a little bit as the timeline is pretty short. I do trust ME which is why I invested heavily in the 2nd to last fundraise but due to financial circumstances and having to fund a new office purchase is why I didn’t invest in the last fundraise, but slightly annoying that my shareholding had halved but hey ho that’s the nature of biotech companies and investing on AIM, as biotech companies have to be spoonfed as they are not revenue producing and all pins on partnering deals which I think will be later in 2026, but I know ME quite well that he’s pretty good at getting funding grants and other ways to pull us through so fingers crossed.

All really annoying at the moment as the traders are just moving the whole Price up and down but I am poised to buy more if we do go sub 30p which may happen as traders get bored as the volatility slows and some investors lose interest but hopefully the New Year might Hopefullyhave some news flow which could help things get moving.

GLA, DYOR, NAI, All I am HO

Getting fed up now with the traders buying and taking 10% and then watching it fall back down again! 😞

So guess we’re gonna have another bouts of selling very soon!

But we have had no TR1’s?

Really ice ?

I would say those that have a position have had a position for some time now (maybe not yourself of course) but what we’re seeing at the moment is trading, otherwise we would’ve been well north of 0.40 by now.

sadly this is up and down like a *****s draws now because this is just traders until news or the market makers pull the plug and drop it and then whoever can’t afford to pay for their trading stock are left holding the baby, but hardly a convincing rally at the moment let’s see how things pan out

Porky, please stop using my name to support your deramping , l still retain a large 8 figure holding and have simply derisked a little.

If the burn is circa £140k pm and was completed end of October then that’s a runway until end of April unless ME can get the 0.50 warrants exercised with positive inflection newsflow.

I personally think any deal will come a little later in 2026 after EO April when all the ducks are lined up but l may be completely wrong there!

GLA, NAO,IMHO, DYOR

Well it looks like that little bit of hot air yesterday is fizzling out as sellers are now coming in and taking their profits and probably more realistic we sit around the mid to high 20p level until we get some news which most probably now into the New Year so good luck everybody and have a great Christmas as I am signing out as I can’t see anything happening now for the time being, albeit l am a +3% shareholder and look forward to the future with VAL.

Blimey up 20% on the fact that ME has a meeting in March 2026 on LinkedIn.

A lot of conjecture here and although the connection is interesting does not mean there is a done deal!

Please DYOR and NAI.

CLX100 inventor Charles Chen:

https://www.linkedin.com/in/charles-chen-843b3035?utm_source=share_via&utm_content=profile&utm_medium=member_ios

Https://www.linkedin.com/posts/%F0%9D%97%9F%F0%9D%97%B6%F0%9D%97%B3%F0%9D%97%B2-%F0%9D%97%BC%F0%9D%97%B3-%F0%9D%97%AE-%F0%9D%97%A3%F0%9D%97%B2%F0%9D%97%BD%F0%9D%98%81%F0%9D%97%B6%F0%9D%97%B1%F0%9D%97%B2-%F0%9D%97%96%F0%9D%97%BF%F0%9D%97%BC%F0%9D%98%80%F0%9D%98%80-share-7401618811776544768-cac5?utm_medium=ios_app&rcm=ACoAAA1LIgwBr8suZ6-q_42u9B82OT6Z-mDlizk&utm_source=social_share_send&utm_campaign=whatsapp

ME is a panellist in March 2026 to discuss how partnerships in peptides are accelerating therapeutic innovation from concept to clinic and incidentally, Mark is one of four panellists of which two are from Astrazeneca!

Wasn’t Astrazeneca where the inventor of CX came from too so I don’t want to read between the lines and DYOR, NAI and IMHO but….

AZN oncology license and deals, FYI….

AstraZeneca's oncology partnership deals often involve substantial total values that include an upfront payment and significant potential milestone payments (development, regulatory, and sales-related). The total potential deal sizes can range from hundreds of millions to over a billion dollars, with some reports mentioning figures up to $15 billion for certain licensing agreements.

Key examples of recent and notable AstraZeneca oncology partnership deals include:

Daiichi Sankyo (Enhertu and Datopotamab deruxtecan): Two major collaborations for antibody-drug conjugates (ADCs).

The first, in March 2019 for trastuzumab deruxtecan (Enhertu), was valued at up to $6.9 billion in total, including $1.35 billion upfront.

The second, in July 2020, was for DS-1062 (Datopotamab deruxtecan) and could potentially be worth up to $6 billion for Daiichi.

CSPC Pharmaceuticals: A 2025 strategic collaboration for AI-driven drug discovery for immuno-oncology and chronic diseases, involving an upfront payment of $110 million and potential milestone payments reaching up to $5.2 billion.

Fusion Pharmaceuticals (Acquisition): A March 2024 agreement to acquire the radiopharmaceutical company for a transaction value of approximately $2.4 billion, including a potential contingent value right.

TeneoTwo (Acquisition): A July 2022 deal to acquire the company and its T-cell engager asset for an upfront payment of $100 million, with potential R&D and commercial milestones bringing the total deal value up to $1.2 billion.

Gracell Biotechnologies (Acquisition): A December 2023 agreement to acquire the cell therapy developer for up to $1.2 billion.

Merck & Co.: A major 2017 collaboration for the oncology drug Lynparza (olaparib), valued at up to $8.5 billion in total.

Actually Viera, due to deposit for an office purchase no I didn’t invest in the recent placing but I have since accumulated and I will continue to as IMHO and NAI, I really do think we are now at the cusps of what many have been waiting for which is price changing inflection points and with CLX, a licensing deal. Fingers crossed and I am guessing that ME doesn’t actually need much runway to get one or two or many of these over the line as the writings on the wall..

I had just over 23 million shares and now have 27 1/2 million shares fortunately buying at below the placing price which was pretty good timing and fortuitous on my part as I thought I’d would miss boat.

DYOR 👍

TR1 came out this week and you can se added and still am 👍

Yes, a long time waiting, but we are nearly there I think and I can see the trolls around in force 😂

Have a lovely weekend everybody.

Hi ice good to hear from you mate and yes it looks like things are finally coming home as we expected. I think the next 4 to 6 months is going to be amazing with fingers crossed of course and all caveats included.

And sorry forgot to say Peels overhang of stock for fees must be also now nearly gone by now. 😁

Bubbling up nicely 👍

Hello ladies, l think we are going to explode l reckon!

Cmon ME!

Don’t be ridiculous Porky, trying to give the moral high ground as I was not disrespecting anybody. The whole post was aimed at Rat and you know that. Do you really think that people on this board that read what you post and Rat posts and others warning them of up-and-coming disaster constantly and have no shareholding can possibly be taken seriously?

Anyway, I’m out of here and I’m not gonna be posting for a long time in fact the only time you might hear from me is when you see my next TR 1.

Ciao and GLA (they actually have a shareholding)